Bellevue Group Ag Boston Scientific Corp Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Boston Scientific Corp stock. As of the latest transaction made, Bellevue Group Ag holds 2,452,797 shares of BSX stock, worth $222 Million. This represents 3.46% of its overall portfolio holdings.

Number of Shares

2,452,797

Previous 2,569,588 4.55%

Holding current value

$222 Million

Previous $198 Million 3.87%

% of portfolio

3.46%

Previous 3.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $8.52 Million - $9.81 Million	-116,791 Reduced 4.55%	2,452,797 $206 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $39 Million - $45 Million	-579,088 Reduced 18.39%	2,569,588 $198 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $1.26 Million - $1.5 Million	-21,927 Reduced 0.69%	3,148,676 $216 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $25.5 Million - $30.3 Million	524,308 Added 19.81%	3,170,603 $183 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $760,729 - $828,784	-15,157 Reduced 0.57%	2,646,295 $140 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $38.7 Million - $42.5 Million	-778,127 Reduced 22.62%	2,661,452 $144 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $20.9 Million - $23.2 Million	-463,345 Reduced 11.87%	3,439,579 $172 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $3.91 Million - $4.67 Million	98,877 Added 2.6%	3,902,924 $181 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1.69 Million - $5.06 Million	-46,124 Reduced 1.2%	3,804,047 $147 Million
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $2.25 Million - $3 Million	-63,776 Reduced 1.63%	3,850,171 $143 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $38.9 Million - $42.8 Million	949,916 Added 32.05%	3,913,947 $173 Million
Q4 2021 Feb 10, 2022	SELL	$38.07 - $44.87 $117,864 - $138,917	-3,096 Reduced 0.1%	2,964,031 $126 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $26.4 Million - $29.4 Million	640,340 Added 27.52%	2,967,127 $129 Million
Q1 2021 May 12, 2021	BUY	$35.27 - $39.67 $4.12 Million - $4.64 Million	116,928 Added 5.29%	2,326,787 $89.9 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $10.7 Million - $13.6 Million	323,562 Added 17.15%	2,209,859 $79.4 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $5.36 Million - $6.57 Million	155,677 Added 9.0%	1,886,297 $72.1 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $5.72 Million - $7.41 Million	189,395 Added 12.29%	1,730,620 $60.8 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $965,938 - $1.71 Million	-37,396 Reduced 2.37%	1,541,225 $50.3 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $6.01 Million - $7.2 Million	158,633 Added 11.17%	1,578,621 $71.4 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $1.58 Million - $1.7 Million	39,206 Added 2.84%	1,419,988 $57.8 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $8.14 Million - $10 Million	233,295 Added 20.33%	1,380,782 $59.3 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $2.98 Million - $3.69 Million	90,598 Added 8.57%	1,147,487 $44 Million
Q4 2018 Feb 12, 2019	BUY	$31.73 - $39.04 $2.47 Million - $3.04 Million	77,960 Added 7.96%	1,056,889 $37.4 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $5.2 Million - $6.12 Million	158,333 Added 19.29%	978,929 $37.7 Million
Q2 2018 Aug 07, 2018	BUY	$26.84 - $34.32 $3.34 Million - $4.28 Million	124,596 Added 17.9%	820,596 $26.8 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $1.79 Million - $1.98 Million	68,000 Added 10.83%	696,000 $20.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	628,000	628,000 $17.4 Million

Others Institutions Holding BSX

# of Institutions

1,541

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Boston Scientific Corp Transaction History